Tweets
Watch Now:
The Sentinel Joint: Dr. Kathryn Dao ( @KDAO2011 ) reviews abstract POS0385 presented at the virtual EULAR 2021 meeting.
https://t.co/H3DcSHQWHr https://t.co/f7LDNz6oyL
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Popular on RheumNow
https://t.co/BZsl8a6ArW
The U.S. Food and Drug Administration (FDA) has approved Octagam 10% [Immune Globulin Intravenous (Human)], as the first and only intravenous immunoglobulin (IVIg) formulation to be approved for adult dermatomyositis (DM). https://t.co/RNFsJadUZx
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Popular post--
AstraZeneca announced that anifrolumab (Saphnelo or anifrolumab-fnia) was approved by the the FDA for that treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy.
https://t.co/22HVA32IAh https://t.co/CGkBW80un4
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
FDA has approved Xywav - gamma-hydroxybutyrate (GHB) for “idiopathic hypersomnia,” (people sleep 9+hrs/, yet never feel rested). GHB prev approved for narcolepsy https://t.co/38MBpmOAAA https://t.co/5pLLghCYtp
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
A Top Tweet this Week:
A large cohort study of rheumatoid arthritis (RA) patients shows that regular tea consumption was associated with a lower risk of RA.
https://t.co/ODTs7PdGTN https://t.co/69mi8IlBdj
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
In case you missed it…
TB rarely causes arthritis; accounts for 1-5% of all TB (10-30% of pulmonary TB) cases. May present as mono/oligoarthritis, tenosynovitis, dactylitis, Spondylitis (Potts disease), reactive arthritis (Poncets dz) or polyarthritis. https://t.co/RpMrRLQbEa
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Dont make a point, make a difference - Seth Godin https://t.co/kJE3EGCY83
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
ICYMI: Can you manage FM without opioids? Study of 698 Fibromyalgia pts from a tertiary center finds 27.1% taking opioids. Opioid associated with longer Sx duration (>3 yrs), increased age, worse functional impairment & pain catastrophizing https://t.co/N1G4ZtkUE5
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
FDA has expanded the use of SHINGRIX vaccine to include adults 18 years and older who are compromised by immunodeficiency or immunosuppression caused by disease or therapy. https://t.co/Wf2mzvOQcU
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
https://t.co/VBxg9fQmt0
Sporadic reports of anakinra use in COVID-19 infection has hinted is potential; now a metanalysis shows that the use of anakinra may reduce the mortality risk in patients admitted to hospital with moderate to severe COVID-19 pneumonia... https://t.co/XIB7OVNCvT
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study https://t.co/XVXgEoufCw Nice data another p19 IL23 inhb - safety continues to impress
Peter Nash @drpnash ( View Tweet )
4 years 11 months ago
New study data on mRNA vaccines in pts with inflammatory diseases on mostly #TNFi +/- #csDMARDs .
▶️ Effective immune response (lower than healthy controls)
▶️Comparable side effects
▶️ no ⬆️ in DAS28
▶️ no pts on #Rituximab included
https://t.co/aexdFoUzer https://t.co/h1S1S2YsHS
Links:
ARD & RMD Open @ARD_BMJ ( View Tweet )
4 years 11 months ago
